•
Dec 31, 2023

REGENXBIO Q4 2023 Earnings Report

Total Revenue
$22.2M
Previous year: $31.3M
-29.1%
EPS
-$1.43
Previous year: -$1.38
+3.6%
Gross Profit
$6.64M
Previous year: $18.6M
-64.2%
Cash and Equivalents
$275M
Previous year: $97M
+183.9%
Free Cash Flow
-$41.9M
Previous year: -$44.8M
-6.6%
Total Assets
$574M
Previous year: $833M
-31.1%

REGENXBIO

REGENXBIO

REGENXBIO Revenue by Segment